FilingSEC EDGAR6-K
NuCana Granted Composition-of-Matter Patent for NUC-7738 in Europe
· SEC accepted
StagePhase 2
Filing content
The company announced that the European Patent Office has granted a composition-of-matter patent for its anti-cancer candidate NUC-7738.
AI summary of the filing. Please also check the source.Related companies
Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…